Effect of nano-curcumin supplementation on angina status, and traditional and novel cardiovascular risk factors in overweight or obese patients with coronary slow flow phenomenon: a randomized double-blind placebo-controlled clinical trial.
Mahsa RezaeiMitra SoltaniElham AlipoorSeyed Mahdi RezayatAli Vasheghani-FarahaniMehdi YaseriAta FirouziMohammad-Javad Hosseinzadeh-AttarPublished in: BMC nutrition (2024)
This study was approved by the Ethics Committee of Tehran University of Medical Sciences (IR.TUMS.VCR.REC.1398.794). The study protocol was registered at Iranian Registry of Clinical Trials by IRCT20131125015536N8 registration ID at 19.06.2019.
Keyphrases
- clinical trial
- double blind
- placebo controlled
- cardiovascular risk factors
- study protocol
- obese patients
- phase ii
- bariatric surgery
- phase iii
- coronary artery disease
- coronary artery
- open label
- weight loss
- roux en y gastric bypass
- cardiovascular disease
- randomized controlled trial
- gastric bypass
- public health
- metabolic syndrome
- phase ii study
- healthcare
- physical activity
- acute coronary syndrome
- percutaneous coronary intervention
- body mass index
- heart failure
- aortic valve
- weight gain
- squamous cell carcinoma